{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:36:23Z","timestamp":1769751383761,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1124002"],"award-info":[{"award-number":["1124002"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["23\/051"],"award-info":[{"award-number":["23\/051"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In New Zealand, BreastScreen Aotearoa (BSA), a biennial national breast screening programme, was implemented in 1998. This study examines the incidence trends of ductal carcinoma in situ (DCIS) in New Zealand women from 1999 to 2022.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>All women with a primary diagnosis of DCIS over the 24-year study period were identified from the New Zealand Cancer Registry and BSA records. Age-standardised incidence rates (ASIR), detection rates (ASDR) and average annual percent changes were calculated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The annual ASIR was 13.5 per 100,000 New Zealand women, and increased by 0.91% (95% confidence interval (CI): 0.26%, 1.66%) annually. Among women aged 45\u201369\u00a0years during 2006\u20132022, the annual ASIR was 36.3 for programme-detected DCIS, increasing 1.29% (95%CI: 0.13%, 2.73%) per year, and 14.2 for non-programme-detected DCIS, with no significant changes over the study period. The programme-detected ASIRs were highest for Pacific (38.6), Asian (38.2), and M\u0101ori (38.0) women. The programme ASDR was 0.55 per 1000 women screened, with no significant changes over time, and was highest for Asian (0.69), and M\u0101ori and Pacific (both at 0.65) women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>DCIS incidence increased in New Zealand women from 1999 to 2022, driven by an increase in screening participation, and varied by ethnicity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10549-024-07582-6","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T02:37:45Z","timestamp":1737772665000},"page":"439-449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence trends of ductal carcinoma in situ in New Zealand women between 1999 and 2022"],"prefix":"10.1007","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4409-9516","authenticated-orcid":false,"given":"Qian","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Cavadino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyu Sin","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandar","family":"Tin Tin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"7582_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","volume":"77","author":"PH Tan","year":"2020","unstructured":"Tan PH, Ellis I, Allison K, Brogi E, Fox SB et al (2020) The 2019 world health organization classification of tumours of the breast. Histopathology 77:181\u2013185. https:\/\/doi.org\/10.1111\/his.14091","journal-title":"Histopathology"},{"key":"7582_CR2","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367:1998\u20132005. https:\/\/doi.org\/10.1056\/NEJMoa1206809","journal-title":"N Engl J Med"},{"key":"7582_CR3","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/1055-9965.EPI-18-1262","volume":"28","author":"MD Ryser","year":"2019","unstructured":"Ryser MD, Hendrix LH, Worni M, Liu Y, Hyslop T, Hwang ES (2019) Incidence of ductal carcinoma in situ in the United States, 2000\u20132014. Cancer Epidemiol Biomarkers Prev 28:1316\u20131323. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-1262","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7582_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.breast.2010.05.014","volume":"19","author":"R Sorum","year":"2010","unstructured":"Sorum R, Hofvind S, Skaane P, Haldorsen T (2010) Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast 19:499\u2013505. https:\/\/doi.org\/10.1016\/j.breast.2010.05.014","journal-title":"Breast"},{"key":"7582_CR5","unstructured":"Ministry of Health. About BreastScreen Aotearoa. Time to Screen. https:\/\/www.timetoscreen.nz\/breast-screening\/having-a-mammogram\/about-the-programme\/. Accessed 4 April 2024"},{"key":"7582_CR6","unstructured":"Independent evaluation of the implementation of digital mammography at breast screen waitemata and northland, Health Outcomes International, Ministry of Health, 2008."},{"key":"7582_CR7","unstructured":"N. Knowlton, A. Lasham, V. Harvey, R. Ramsaroop, S. Kleinsman, A. Gautier (2022) 30,000 voices: Informing a better future for breast cancer in Aotearoa New Zealand."},{"key":"7582_CR8","volume-title":"(2023) National Screening Unit","author":"New Breast Cancer Diagnoses and Treatments","year":"2020","unstructured":"New Breast Cancer Diagnoses and Treatments (2020) (2023) National Screening Unit. Te Whatu Ora, Wellington"},{"key":"7582_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"7582_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12885-016-2781-4","volume":"16","author":"AM Teng","year":"2016","unstructured":"Teng AM, Atkinson J, Disney G, Wilson N, Sarfati D et al (2016) Ethnic inequalities in cancer incidence and mortality: census-linked cohort studies with 87 million years of person-time follow-up. BMC Cancer 16:755. https:\/\/doi.org\/10.1186\/s12885-016-2781-4","journal-title":"BMC Cancer"},{"key":"7582_CR11","unstructured":"Ministry of Health, New Zealand Cancer Registry, 2024. https:\/\/www.tewhatuora.govt.nz\/for-the-health-sector\/health-sector-guidance\/diseases-and-conditions\/cancer\/new-zealand-cancer-registry-nzcr\/. Accessed 29 Feb 2024"},{"key":"7582_CR12","unstructured":"Quality Improvement Review of Clinical Quality and Safety for Breast Screening Aotearoa, Health New Zealand, 2022."},{"key":"7582_CR13","unstructured":"Ministry of Health, HISO 10001:2017 ethnicity data protocols. 2017."},{"key":"7582_CR14","unstructured":"S.C. Atkinson J, Crampton P, (2019) NZDep2018 index of deprivation, Final research report, December 2020. , Wellington: University of Otago"},{"key":"7582_CR15","unstructured":"New Zealand Census Statistics, Population estimates and projections. https:\/\/www.stats.govt.nz\/topics\/population-estimates-and-projections. Accessed 29 Feb 2024"},{"key":"7582_CR16","volume-title":"Age standardization of rates: a new WHO standard","author":"OB Ahmad","year":"2001","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M (2001) Age standardization of rates: a new WHO standard. World Health Organization, Geneva"},{"key":"7582_CR17","unstructured":"National Screening Unit, BreastScreen Aotearoa DHB Coverage Report, 2024. https:\/\/tewhatuora.shinyapps.io\/nsu-bsa-coverage\/. Accessed 20th May 2024"},{"key":"7582_CR18","unstructured":"Statistical Methodology and Applications Branch SRP, National Cancer Institute. Joinpoint Trend Analysis Software. Version 5.1.0. https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed April 2024"},{"key":"7582_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335\u2013351","journal-title":"Stat Med"},{"key":"7582_CR20","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK (2009) Estimating average annual per cent change in trend analysis. Stat Med 28:3670\u20133682. https:\/\/doi.org\/10.1002\/sim.3733","journal-title":"Stat Med"},{"key":"7582_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1158\/1055-9965.EPI-15-0535","volume":"24","author":"CE DeSantis","year":"2015","unstructured":"DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO et al (2015) International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prevent 24:1495\u20131506. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0535","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"7582_CR22","unstructured":"R.C. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria., 2023. https:\/\/www.R-project.org\/."},{"key":"7582_CR23","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF (2014) A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 23:2296\u20132302. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0300","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7582_CR24","unstructured":"Netherlands Cancer Registry, Ductal carcinoma in situ, 2023. https:\/\/nkr-cijfers.iknl.nl\/viewer\/incidentie-per-jaar?language=en_GB&viewerId=c9aacce7-b92f-440d-a5f8-6dc5083b0dd5. Accessed 18 April 2024"},{"key":"7582_CR25","unstructured":"In situ breast carcinoma incidence statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer\/incidence-in-situ."},{"key":"7582_CR26","unstructured":"BreastScreen Australia Monitoring Report 2023, Australian Institute of Health and Welfare, 2023."},{"key":"7582_CR27","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.canep.2023.102481","volume":"87","author":"AH Eijkelboom","year":"2023","unstructured":"Eijkelboom AH, de Munck L, Larsen M, Bijlsma MJ, Tjan-Heijnen VC et al (2023) Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: a population-based study. Cancer Epidemiol 87:102481. https:\/\/doi.org\/10.1016\/j.canep.2023.102481","journal-title":"Cancer Epidemiol"},{"key":"7582_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00432-018-2822-2","volume":"145","author":"N Karavasiloglou","year":"2019","unstructured":"Karavasiloglou N, Matthes KL, Berlin C, Limam M, Wanner M et al (2019) Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003\u20132014. J Cancer Res Clin Oncol 145:653\u2013660. https:\/\/doi.org\/10.1007\/s00432-018-2822-2","journal-title":"J Cancer Res Clin Oncol"},{"key":"7582_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10549-014-3073-9","volume":"147","author":"F Molinie","year":"2014","unstructured":"Molinie F, Vanier A, Woronoff A-S, Guizard A-V, Delafosse P et al (2014) Trends in breast cancer incidence and mortality in France 1990\u20132008. Breast Cancer Res Treat 147:167\u2013175. https:\/\/doi.org\/10.1007\/s10549-014-3073-9","journal-title":"Breast Cancer Res Treat"},{"key":"7582_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4048\/jbc.2023.26.e27","volume":"26","author":"JE Choi","year":"2023","unstructured":"Choi JE, Kim Z, Park CS, Park EH, Lee SB et al (2023) Breast cancer statistics in Korea, 2019. J Breast Cancer 26:207\u2013220. https:\/\/doi.org\/10.4048\/jbc.2023.26.e27","journal-title":"J Breast Cancer"},{"key":"7582_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/ijc.32767","volume":"147","author":"A Katalinic","year":"2020","unstructured":"Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, H\u00fcbner J (2020) Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer 147:709\u2013718. https:\/\/doi.org\/10.1002\/ijc.32767","journal-title":"Int J Cancer"},{"key":"7582_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3322\/caac.21321","volume":"65","author":"EM Ward","year":"2015","unstructured":"Ward EM, DeSantis CE, Lin CC, Kramer JL, Jemal A et al (2015) Cancer statistics: breast cancer in situ. CA Cancer J Clin 65:481\u2013495. https:\/\/doi.org\/10.3322\/caac.21321","journal-title":"CA Cancer J Clin"},{"key":"7582_CR33","volume-title":"Impact analysis: Extending breastscreen aotearoa to include women aged 70\u201374 years","author":"Ministry of Health","year":"2019","unstructured":"Ministry of Health (2019) Impact analysis: Extending breastscreen aotearoa to include women aged 70\u201374 years. Ministry of Health, Wellington"},{"key":"7582_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075498","volume":"384","author":"GS Mannu","year":"2024","unstructured":"Mannu GS, Wang Z, Dodwell D, Broggio J, Charman J, Darby SC (2024) Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study. BMJ 384:e075498. https:\/\/doi.org\/10.1136\/bmj-2023-075498","journal-title":"BMJ"},{"key":"7582_CR35","doi-asserted-by":"publisher","first-page":"17623","DOI":"10.1038\/s41598-020-74134-5","volume":"10","author":"AS Agustsson","year":"2020","unstructured":"Agustsson AS, Birgisson H, Agnarsson BA, Jonsson T, Stefansdottir H et al (2020) In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden. Sci Rep 10:17623. https:\/\/doi.org\/10.1038\/s41598-020-74134-5","journal-title":"Sci Rep"},{"key":"7582_CR36","unstructured":"National Cancer Institute, Breast Cancer Screening, Online Summary of Trends in US Cancer Control Measures, 2024. https:\/\/progressreport.cancer.gov\/detection\/breast_cancer. Accessed 4 April 2024"},{"key":"7582_CR37","unstructured":"National Screening Unit, Te Whatu Ora, Wellington. BreastScreen Aotearoa 2017 Monitoring Report 2017."},{"key":"7582_CR38","unstructured":"BreastScreen Aotearoa National Policy and Quality Standards, Ministry of Health, 2013(revised November 2022)."},{"key":"7582_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jamcollsurg.2019.01.018","volume":"228","author":"TO Oseni","year":"2019","unstructured":"Oseni TO, Zhang B, Coopey SB, Gadd MA, Hughes KS, Chang DC (2019) Twenty-five year trends in the incidence of ductal carcinoma in situ in US women. J Am Coll Surg 228:932\u2013939. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2019.01.018","journal-title":"J Am Coll Surg"},{"key":"7582_CR40","unstructured":"A. Ponti, A. Anttila, G. Ronco, C. Senore, (2017) Cancer screening in the European Union. Report on the implementation of the council recommendation on cancer screening. https:\/\/health.ec.europa.eu\/document\/download\/911ecf9b-0ae2-4879-93e6-b750420e9dc0_en."},{"key":"7582_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2013.08.013","volume":"50","author":"E Lynge","year":"2014","unstructured":"Lynge E, Ponti A, James T, M\u00e1jek O, von Euler-Chelpin M et al (2014) Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the international cancer screening network. Europ J Cancer 50:185\u2013192. https:\/\/doi.org\/10.1016\/j.ejca.2013.08.013","journal-title":"Europ J Cancer"},{"key":"7582_CR42","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1148\/radiol.2015150322","volume":"278","author":"S Weigel","year":"2016","unstructured":"Weigel S, Hense HW, Heidrich J, Berkemeyer S, Heindel W, Heidinger OJR (2016) Digital mammography screening: does age influence the detection rates of low-, intermediate-, and high-grade ductal carcinoma in situ? Radiology 278:707\u2013713. https:\/\/doi.org\/10.1148\/radiol.2015150322","journal-title":"Radiology"},{"key":"7582_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.0166","volume":"6","author":"BL Sprague","year":"2023","unstructured":"Sprague BL, Chen S, Miglioretti DL, Gard CC, Tice JA et al (2023) Cumulative 6-year risk of screen-detected ductal carcinoma in situ by screening frequency. JAMA Netw Open 6:e230166. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.0166","journal-title":"JAMA Netw Open"},{"key":"7582_CR44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/1471-2407-10-674","volume":"10","author":"R Cunningham","year":"2010","unstructured":"Cunningham R, Shaw C, Blakely T, Atkinson J, Sarfati D (2010) Ethnic and socioeconomic trends in breast cancer incidence in New Zealand. BMC Cancer 10:674. https:\/\/doi.org\/10.1186\/1471-2407-10-674","journal-title":"BMC Cancer"},{"key":"7582_CR45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","volume":"124","author":"AM Shaaban","year":"2021","unstructured":"Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S et al (2021) Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK sloane project. Br J Cancer 124:1009\u20131017. https:\/\/doi.org\/10.1038\/s41416-020-01152-5","journal-title":"Br J Cancer"},{"key":"7582_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10549-020-06055-w","volume":"187","author":"JD Luiten","year":"2021","unstructured":"Luiten JD, Luiten EJT, van der Sangen MJC, Vreuls W, Duijm LEM et al (2021) Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands. Breast Cancer Res Treat 187:245\u2013254. https:\/\/doi.org\/10.1007\/s10549-020-06055-w","journal-title":"Breast Cancer Res Treat"},{"key":"7582_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10549-023-07168-8","volume":"204","author":"S Alaeikhanehshir","year":"2024","unstructured":"Alaeikhanehshir S, Schmitz R, van den Belt-Dusebout AW, van Duijnhoven FH, Verschuur E et al (2024) The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive breast cancer (iIBC) in the dutch population. Breast Cancer Res Treat 204:61\u201368. https:\/\/doi.org\/10.1007\/s10549-023-07168-8","journal-title":"Breast Cancer Res Treat"},{"key":"7582_CR48","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/ans.16970","volume":"91","author":"S Omling","year":"2021","unstructured":"Omling S, Houssami N, McGeechan K, Zackrisson S, Jacklyn G et al (2021) The management of women with ductal carcinoma in situ of the breast in Australia and New Zealand between 2007 and 2016. ANZ J Surg 91:1784\u20131791. https:\/\/doi.org\/10.1111\/ans.16970","journal-title":"ANZ J Surg"},{"key":"7582_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1570","volume":"369","author":"GS Mannu","year":"2020","unstructured":"Mannu GS, Wang Z, Broggio J, Charman J, Cheung S et al (2020) Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988\u20132014: population based observational cohort study. BMJ 369:m1570. https:\/\/doi.org\/10.1136\/bmj.m1570","journal-title":"BMJ"},{"key":"7582_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13058-016-0705-5","volume":"18","author":"PA van Luijt","year":"2016","unstructured":"van Luijt PA, Heijnsdijk EA, Fracheboud J, Overbeek LI, Broeders MJ et al (2016) The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Res 18:47. https:\/\/doi.org\/10.1186\/s13058-016-0705-5","journal-title":"Breast Cancer Res"},{"key":"7582_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jms.8.3.149","volume":"8","author":"AJ Evans","year":"2001","unstructured":"Evans AJ, Pinder SE, Ellis IO, Wilson AR (2001) Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen 8:149\u2013151. https:\/\/doi.org\/10.1136\/jms.8.3.149","journal-title":"J Med Screen"},{"key":"7582_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13058-017-0819-4","volume":"19","author":"LE Elshof","year":"2017","unstructured":"Elshof LE, Schaapveld M, Rutgers EJ, Schmidt MK, de Munck L et al (2017) The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study. Breast Cancer Res 19:26. https:\/\/doi.org\/10.1186\/s13058-017-0819-4","journal-title":"Breast Cancer Res"},{"key":"7582_CR53","doi-asserted-by":"publisher","first-page":"912","DOI":"10.2214\/AJR.20.23314","volume":"216","author":"CH Neal","year":"2021","unstructured":"Neal CH, Joe AI, Patterson SK, Pujara AC, Helvie MA (2021) Digital mammography has persistently increased high-grade and overall DCIS detection without altering upgrade rate. Am J Roentgenol 216:912\u2013918. https:\/\/doi.org\/10.2214\/AJR.20.23314","journal-title":"Am J Roentgenol"},{"key":"7582_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1148\/radiol.13131498","volume":"271","author":"S Weigel","year":"2014","unstructured":"Weigel S, Heindel W, Heidinger O, Berkemeyer S, Hense HWJR (2014) Digital mammography screening: association between detection rate and nuclear grade of ductal carcinoma in situ. Radiology 271:38\u201344. https:\/\/doi.org\/10.1148\/radiol.13131498","journal-title":"Radiology"},{"key":"7582_CR55","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/bjc.2017.6","volume":"116","author":"S Morrell","year":"2017","unstructured":"Morrell S, Taylor R, Roder D, Robson B, Gregory M, Craig K (2017) Mammography service screening and breast cancer mortality in New Zealand: a national cohort study 1999\u20132011. Br J Cancer 116:828\u2013839. https:\/\/doi.org\/10.1038\/bjc.2017.6","journal-title":"Br J Cancer"},{"key":"7582_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejca.2017.04.013","volume":"80","author":"T Onega","year":"2017","unstructured":"Onega T, Weaver DL, Frederick PD, Allison KH, Tosteson ANA et al (2017) The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer 80:39\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2017.04.013","journal-title":"Eur J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07582-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07582-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T02:36:10Z","timestamp":1742783770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07582-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["7582"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07582-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Auckland Health Research Ethics Committee (Ref. AH26746).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}